CSGN.SW Credit Suisse (SIX) intraday 11 Feb 2026: CHF0.82 on surge in volume

CSGN.SW stock is among Switzerland’s most active names intraday on 11 Feb 2026, trading at CHF 0.82 as volume hits 41,886,101 shares. The activity comes with a price range of CHF 0.81–0.82 for the session and a relative volume of 1.23, signalling above-normal liquidity on the SIX market. Investors are parsing weak earnings history, a steep 200-day average gap, and large book value per share when sizing risk and opportunity. This update covers intraday drivers, valuation, a Meyka AI grade, and a model forecast to frame trading decisions.

Intraday snapshot of CSGN.SW stock

Credit Suisse Group AG (CSGN.SW) on SIX is trading at CHF 0.817 with a session low of CHF 0.81 and high of CHF 0.82. Volume stands at 41,886,101 versus average volume 34,154,216, showing a 1.23x pickup in liquidity. The 50-day average is CHF 0.79 and the 200-day average is CHF 2.72, underlining a steep downward re-rating over longer horizons.

Trading drivers and CSGN.SW news flow

There is no fresh earnings release today; the last public earnings announcement in our dataset is dated 2023-07-27. Market interest appears driven by restructuring rumours, balance-sheet scrutiny, and sector rotation within Financial Services, where the 1M sector performance is -6.50%. For company filings and corporate updates see Credit Suisse’s site source.

Valuation and fundamentals for CSGN.SW stock

Key fundamentals show EPS -2.57, a negative PE, and book value per share CHF 18.45, producing a price-to-book ratio of 0.04. Market cap sits at CHF 3,224,617,274.00 with 3,946,899,968 shares outstanding. Debt metrics are heavy: debt-to-equity is 3.81 versus the Financial Services sector average 1.67, indicating higher leverage risk.

Meyka AI rates CSGN.SW with a score out of 100

Meyka AI rates CSGN.SW with a score out of 100: 62.91 / 100 — Grade B, Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The score reflects solid book value and cash per share but penalises negative earnings, high leverage, and volatile price action. These grades are not guaranteed and we are not financial advisors.

CSGN.SW forecast and scenarios

Meyka AI’s forecast model projects a base-case 12‑month price of CHF 1.20, implying an upside of 46.87% from the current CHF 0.817. A conservative scenario points to CHF 0.50 (downside -38.81%) if capital dilution or further write‑downs occur. Forecasts are model-based projections and not guarantees.

Risks, opportunities and trading considerations

Primary risks are ongoing losses, regulatory/legal exposure, and potential share issuance that would dilute equity. Opportunities include accelerated asset sales, restructuring gains, and support from high tangible book value (CHF 17.08 per share). Traders should note extreme volatility history: 6‑month change -74.44% and 1‑year change -85.15%, and size positions to liquidity shown by today’s volume.

Final Thoughts

CSGN.SW stock is trading as one of Switzerland’s most active intraday stocks on 11 Feb 2026, with CHF 0.817 per share and 41,886,101 trades highlighting elevated liquidity. Valuation is extreme: negative EPS (-2.57) and a tiny price‑to‑book of 0.04 against a high book value per share (CHF 18.45). Meyka AI assigns a 62.91 / 100 (Grade B, HOLD) reflecting strong balance-sheet line items but weak profitability and high leverage. Meyka AI’s forecast model projects CHF 1.20 in 12 months, an implied 46.87% upside, while a downside stress case at CHF 0.50 implies -38.81%. Traders should balance short-term liquidity and news catalysts against structural risks such as dilution and legal exposure. Use tight risk controls, size positions carefully, and watch official Credit Suisse updates and SIX trading notices for intraday shifts

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.